Please login to the form below

Not currently logged in
Email:
Password:

Icon appoints Hugh Brady to board

He is former president of University College Dublin
ICON Hugh Brady

The contract research organisation (CRO) ICON has appointed Dr Hugh Brady to its board of directors.

Dr Brady is former president of University College Dublin (UCD) in Ireland, where he served from 2004 to 2013.

During this time he oversaw the expansion of the University's science, engineering and biomedical research capacity, including the development of several new research centres.

He also built links across the world, establishing the Beijing-Dublin International College and the UCD Shenzhen Health Sciences Institute in China.

In his role at Icon Dr Brady will be able to offer an in-depth knowledge of academia and research networks to Icon's efforts to support the pharma, biotech and medical device industries.

Thomas Lynch, chairman of Icon said: “His inspirational leadership of UCD, Irelands' largest university, during the past ten years, extensive international experience, especially in Asia, coupled with a distinguished career as an academic clinician in Ireland and the US will bring invaluable experience and expertise to Icon.”

2nd May 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics